PDE4D haploinsufficiency syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:439822OMIM:615668Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

PDE4D haploinsufficiency syndrome is a rare genetic condition caused by having only one working copy of the PDE4D gene instead of the usual two. This gene provides instructions for making an enzyme called phosphodiesterase 4D, which plays an important role in chemical signaling within cells, particularly in the brain and bones. When one copy of this gene is missing or not working properly, it can lead to a range of developmental and physical problems. The main features of this syndrome include intellectual disability or learning difficulties, delayed speech and language development, and distinctive facial features. Many affected individuals also have skeletal abnormalities, particularly involving the fingers and toes (brachydactyly), as well as short stature. Some children may experience behavioral challenges, including attention difficulties and features of autism spectrum disorder. The severity of symptoms can vary widely from person to person, even within the same family. There is currently no cure for PDE4D haploinsufficiency syndrome. Treatment focuses on managing individual symptoms through therapies such as speech therapy, occupational therapy, special education support, and behavioral interventions. Regular monitoring by a team of specialists helps ensure that each person receives the care they need to reach their full potential.

Key symptoms:

Intellectual disability or learning difficultiesDelayed speech and language developmentShort statureShort fingers and toes (brachydactyly)Distinctive facial featuresLow muscle tone in infancyDelayed motor milestones such as walkingBehavioral challenges including attention problemsFeatures of autism spectrum disorder in some individualsBroad or flat nasal bridgeSmall head size (microcephaly) in some casesFeeding difficulties in early childhoodSkeletal abnormalities

Clinical phenotype terms (50)— hover any for plain English
Broad metacarpalsHP:0001230Broad footHP:0001769Broad metatarsalHP:0001783Broad phalanxHP:0006009Short phalanx of fingerHP:0009803Broad halluxHP:0010055Short metatarsalHP:0010743
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for PDE4D haploinsufficiency syndrome.

View clinical trials →

No actively recruiting trials found for PDE4D haploinsufficiency syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the PDE4D haploinsufficiency syndrome community →

No specialists are currently listed for PDE4D haploinsufficiency syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to PDE4D haploinsufficiency syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open PDE4D haploinsufficiency syndromeForum →

No community posts yet. Be the first to share your experience with PDE4D haploinsufficiency syndrome.

Start the conversation →

Latest news about PDE4D haploinsufficiency syndrome

No recent news articles for PDE4D haploinsufficiency syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my child's condition based on the genetic findings?,What therapies should we start right away, and how often should they occur?,Are there any other medical tests or screenings my child needs?,How should we monitor my child's growth and development over time?,What educational supports and accommodations should we request at school?,Is there a risk that future children could also have this condition?,Are there any research studies or clinical trials we should know about?

Common questions about PDE4D haploinsufficiency syndrome

What is PDE4D haploinsufficiency syndrome?

PDE4D haploinsufficiency syndrome is a rare genetic condition caused by having only one working copy of the PDE4D gene instead of the usual two. This gene provides instructions for making an enzyme called phosphodiesterase 4D, which plays an important role in chemical signaling within cells, particularly in the brain and bones. When one copy of this gene is missing or not working properly, it can lead to a range of developmental and physical problems. The main features of this syndrome include intellectual disability or learning difficulties, delayed speech and language development, and disti

How is PDE4D haploinsufficiency syndrome inherited?

PDE4D haploinsufficiency syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does PDE4D haploinsufficiency syndrome typically begin?

Typical onset of PDE4D haploinsufficiency syndrome is childhood. Age of onset can vary across affected individuals.